###begin article-title 0
###xml 100 108 <span type="species:ncbi:9606">Patients</span>
Association of MCP-1 -2518 A/G Single Nucleotide Polymorphism with the Serum Level of CRP in Slovak Patients with Ischemic Heart Disease, Angina Pectoris, and Hypertension
###end article-title 0
###begin p 1
Recommended by Sunit Kumar Singh
###end p 1
###begin p 2
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 704 705 704 705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 850 851 850 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 865 866 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 884 885 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 938 939 938 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 353 361 <span type="species:ncbi:9606">patients</span>
###xml 557 565 <span type="species:ncbi:9606">patients</span>
###xml 683 691 <span type="species:ncbi:9606">patients</span>
###xml 831 839 <span type="species:ncbi:9606">patients</span>
###xml 929 932 <span type="species:ncbi:9606">men</span>
###xml 1023 1031 <span type="species:ncbi:9606">patients</span>
The aim of our work was to find if MCP-1 -2518 (A/G) single nucleotide polymorphism (SNP) influences somehow the serum concentrations of high-sensitive CRP (hsCRP) both in patients suffering from ischemic heart disease (IHD), myocardial infarction (MI), angina pectoris (AP), and hypertension (HT) and in control group of healthy subjects. Totally, 263 patients with the diagnosis of IHD, out of them 89 with MI, 145 with AP, 205 with HT, and also 67 healthy subjects were included in the study. First, we estimated the serum levels of hsCRP. We found that patients with AP had significantly higher serum level of hsCRP than both control group of healthy subjects (P = .043) and IHD patients without AP (P = .026). The presence of the mutant G allele statistically significantly correlated with the higher serum levels of hsCRP in patients with IHD (P = .016), AP (P = .004), and HT (P = .013). Higher correlations were found in men (AP: P = .019; HT: P = .047). In all cases the highest levels of hsCRP were found both in patients and healthy controls with homozygous GG genotype.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
Inflammation is a bodily response to tissue injury or irritation and primarily facilitates restoration of tissue health. It can be induced not only by infection but also by processes associated with any type of cell, tissue, or organ damage.
###end p 4
###begin p 5
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 110 111 110 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 350 351 350 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 352 353 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
Chronic low-grade inflammation has an important role also in the ethiology of coronary heart disease (CHD) [1-3]. Several studies have shown that elevated plasma levels of C-reactive protein (CRP), interleukin-6 (IL-6), fibrinogen and other soluble inflammatory mediators are associated with both the severity of atherosclerosis and the risk of CHD [4-7].
###end p 5
###begin p 6
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
There is a possibility that individuals vary in their sensitivity to the general background of intercurrent low-grade acute-phase stimuli to which everybody is exposed, and that those who are higher "CRP responders" through genetic and/or acquired mechanisms are also more susceptible to progression and complications of atherosclerosis [8].
###end p 6
###begin p 7
###xml 597 598 597 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 721 722 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1216 1218 1216 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1220 1222 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 303 311 <span type="species:ncbi:9606">patients</span>
The aim of our work was to find if MCP-1 -2518 (A/G) single nucleotide polymorphism (SNP) influences somehow the tested concentrations of hsCRP both in patients suffering from ischemic heart disease (IHD), myocardial infarction (MI), angina pectoris (AP), and hypertension (HT) within the cohort of IHD patients and in control group of healthy subjects. The reason for our intention was that the chemokine MCP-1/CCL2 belongs to key inflammatory CC chemokines playing central role in atherosclerosis and cardiovascular disease development-disease states guided with chronic low-grade inflammation [9-11]. MCP-1/CCL2 is a potent chemoattractant for monocytes, T cells, and NK cells. MCP-1 induces the transmigration of CCR2+ monocytes from the circulation, promotes their differentiation to lipid laden macrophages, and contributes to the proliferation of arterial smooth muscle cells. This chemokine plays a dual role in myocardial ischaemia. In addition to several negative roles in the process of atherosclerosis, thrombotic occlusion of coronary artery, and in the process of reperfusion, this chemokine protects myocytes from hypoxia-induced cell death and has also positive effect in myocardial infarct healing [12, 13].
###end p 7
###begin title 8
2. Materials and Methods
###end title 8
###begin title 9
###xml 5 13 <span type="species:ncbi:9606">Patients</span>
2.1. Patients and Controls
###end title 9
###begin p 10
###xml 157 158 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 261 262 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 382 383 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 564 565 548 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 671 673 655 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 675 677 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 678 679 662 663 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 680 688 <span type="species:ncbi:9606">Patients</span>
Our case control study with determined MCP-1 polymorphism comprised 263 patients with IHD (118 males/145 females, mean age 61.52 +/- 10.173/64.16 +/- 7.543; P = .02), out of them 89 with MI (55 males/34 females, mean age 59.71 +/- 10.031/64.62 +/- 6.448 years; P = .006) as well as 145 with angina pectoris (AP) (59 males/86 females, mean age 60.71 +/- 9.837/64.09 +/- 7.575 years, P = .028). The control group comprised of 67 healthy subjects from a region Velky Lom in middle Slovakia (36 males/31 females, mean age 50.33 +/- 10.690 years/49.71 +/- 9.353 years. P = .802). They have the same MCP-1 gene prevalence as healthy subjects from whole Slovakia tested before [10, 14]. Patients and control subjects were unrelated and of Caucasian origin. The study was approved by the local Ethics Committee (Faculty of Medicine Comenius University, Bratislava), and all subjects signed an informed consent.
###end p 10
###begin p 11
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 85 93 <span type="species:ncbi:9606">Patients</span>
###xml 621 629 <span type="species:ncbi:9606">patients</span>
###xml 657 665 <span type="species:ncbi:9606">patients</span>
###xml 790 798 <span type="species:ncbi:9606">patients</span>
The original cohort of patients was enrolled in 1999-2000 for the Homocystein Study. Patients with ischemic heart disease were recruited from cardiological register of Cardiological laboratory of the second Department of Internal Medicine, Comenius University in Bratislava (standardized mortality 9.8), cardiological registers of two specialists in Nove Zamky (stardardized mortality 10.4), and one register in Velky Lom (standardized mortality 12.6). Randomization was made according to random tables by independent researchers. Basic characteristics (structure of sex, age, and diseases) were analyzed in both groups (patients recruited into project and patients excluded). Subjects in whom ischemic heart disease (according to below mentioned criteria) was diagnosed were considered as patients; apparently healthy subjects were considered as controls.
###end p 11
###begin p 12
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
Ischemic heart disease (IHD) was defined as documented myocardial infarction (hospitalization or coronarography), or presence of documented typical angina pectoris (ECG or Holter) or documented silent ischemia (ECG, Holter, ECG or exercise test), or pathological finding on coronary arteries during selective coronarography or other interventions. Typical angina pectoris was defined as substernal chest discomfort with a characteristic quality and duration that is provoked by exertion or emotional stress and is relieved by rest or nitroglycerin [15]. It was also documented by ECG ST segment deviation (exercise test, Holter, or ECG at rest) reacting to antianginal therapy. Arterial hypertension was defined as increased blood pressure >/=140/90 mm Hg measured using standard protocol or normotension on antihypertensive therapy. Blood pressure was measured in a separate quiet room after 5 minutes in sitting position three times by sphygnomanometer using auscultatory method.
###end p 12
###begin p 13
###xml 110 112 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Cardiovascular symptomatology in control subjects was evaluated according to the standard Rose questionnaire [16] and, additionally, in 55% of control subjects by exercise electrocardiography.
###end p 13
###begin p 14
Complete personal and medical history was taken by qualified physicians, who underwent training to obtain standardized data. Analyzed parameters included whole blood count, complete lipid profile (total cholesterol, triglycerides, apoprotein B, apoprotein AI, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol), glucose, total antioxidant status, homocysteine and vitamins B status, inflammatory markers, and several oxidative stress parameters.
###end p 14
###begin title 15
2.2. Assessment of MCP-1 -2518 SNP
###end title 15
###begin p 16
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 279 280 279 280 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</bold>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
Genomic DNA was extracted using a standard salting out procedure [17]. MCP-1 wild-type (A) and mutant (G) alleles were typed by polymerase chain reaction using sequence specific primers (PCR-SSP). Two reaction formats with specific reactions either to A or G allele of the MCP-1 -2518 SNP were used, and an internal control was adopted from phototyping [14]. The sequences of specific primers were allele A, forward: 5'GTG GGA GGC AGA CAG CTA; allele G, forward: 5' GTG GGA GGC AGA CAG CTG; constant reverse: 5'TGA GTG TTC ACA TAG GCT TC. The PCR mixture was according to Phototyping [18]. PCR amplification was carried out using a PTC-100 Thermal Cycler (MJ Research, Inc., Waltham, Mass, USA). The cycling protocol was described earlier [19]. MCP-1 -2518 genotypes were assessed from the presence/absence of PCR amplicons specific to the particular alleles in a standard 2% agarose gel stained with ethidium-bromide.
###end p 16
###begin title 17
2.3. CRP Level Determination
###end title 17
###begin p 18
###xml 26 34 <span type="species:ncbi:9606">patients</span>
The serum level of CRP in patients and control subjects was determined turbidimetrically by an ADVIA instrument (Bayer Corporation, Tarrytown, New York, USA) with reagents from Randox Laboratories, Ltd. (Crumlin, UK).
###end p 18
###begin title 19
2.4. Statistics
###end title 19
###begin p 20
###xml 91 94 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;</italic>
###xml 94 95 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 453 454 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 192 200 <span type="species:ncbi:9606">patients</span>
The populations were tested for conformity to the Hardy-Weinberg equilibrium using a 2 x 2 chi2 test between observed and expected numbers. Levels of hsCRP between controls and (sub)groups of patients were compared by Mann-Whitney U-test. The association of genotypes with the levels of hsCRP was statistically evaluated by Kruskal-Wallis test, and for comparison of hsCRP concentrations to particular genotypes the Bonferonni Post Hoc test was used. A P-value < .05 was considered to be significant.
###end p 20
###begin title 21
3. Results
###end title 21
###begin title 22
###xml 30 38 <span type="species:ncbi:9606">Patients</span>
3.1. Serum Levels of hsCRP in Patients with IHD, MI, AP, and HT, and in Control Group of Healthy Subjects
###end title 22
###begin p 23
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 287 288 287 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 298 305 298 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 166 174 <span type="species:ncbi:9606">patients</span>
###xml 266 274 <span type="species:ncbi:9606">patients</span>
The serum levels of hsCRP in patients with estimated diagnosis were higher than those in control group of healthy subjects. The highest levels of hsCRP were found in patients with AP (P = .043). These levels were statistically significantly higher than those in IHD patients without AP (P = .026) (Table 1).
###end p 23
###begin p 24
###xml 0 26 0 26 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="25">Hardy-Weinberg Equilibrium</title>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 429 430 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 485 486 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 502 503 502 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 26 530 26 530 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="26">The healthy control group was in Hardy-Weinberg equilibrium (HWE) with regard to the distribution of the MCP-1 -2518 A/G genotypes (<italic>P</italic> &gt; .05); observed MCP-1 -2518 G allele frequency was similar to the data reported previously from other Caucasian populations [<xref ref-type="bibr" rid="B20">20</xref>]. However, IHD patients were slightly deviated from HWE due to the higher frequency of GG genotype and lower frequency of AG heterozygotes (<italic>P</italic> = .02). Similarly, subgroups of IHD patients with MI (<italic>P</italic> = .04) and AP (<italic>P</italic> = .00002) were not in HWE.</p>
###xml 0 530 0 530 <statement xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="head1"><title textid="25">Hardy-Weinberg Equilibrium</title><p textid="26">The healthy control group was in Hardy-Weinberg equilibrium (HWE) with regard to the distribution of the MCP-1 -2518 A/G genotypes (<italic>P</italic> &gt; .05); observed MCP-1 -2518 G allele frequency was similar to the data reported previously from other Caucasian populations [<xref ref-type="bibr" rid="B20">20</xref>]. However, IHD patients were slightly deviated from HWE due to the higher frequency of GG genotype and lower frequency of AG heterozygotes (<italic>P</italic> = .02). Similarly, subgroups of IHD patients with MI (<italic>P</italic> = .04) and AP (<italic>P</italic> = .00002) were not in HWE.</p></statement>
###xml 304 312 <span type="species:ncbi:9606">patients</span>
###xml 467 475 <span type="species:ncbi:9606">patients</span>
Hardy-Weinberg EquilibriumThe healthy control group was in Hardy-Weinberg equilibrium (HWE) with regard to the distribution of the MCP-1 -2518 A/G genotypes (P > .05); observed MCP-1 -2518 G allele frequency was similar to the data reported previously from other Caucasian populations [20]. However, IHD patients were slightly deviated from HWE due to the higher frequency of GG genotype and lower frequency of AG heterozygotes (P = .02). Similarly, subgroups of IHD patients with MI (P = .04) and AP (P = .00002) were not in HWE.
###end p 24
###begin title 25
Hardy-Weinberg Equilibrium
###end title 25
###begin p 26
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 459 460 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 476 477 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 278 286 <span type="species:ncbi:9606">patients</span>
###xml 441 449 <span type="species:ncbi:9606">patients</span>
The healthy control group was in Hardy-Weinberg equilibrium (HWE) with regard to the distribution of the MCP-1 -2518 A/G genotypes (P > .05); observed MCP-1 -2518 G allele frequency was similar to the data reported previously from other Caucasian populations [20]. However, IHD patients were slightly deviated from HWE due to the higher frequency of GG genotype and lower frequency of AG heterozygotes (P = .02). Similarly, subgroups of IHD patients with MI (P = .04) and AP (P = .00002) were not in HWE.
###end p 26
###begin title 27
###xml 44 52 <span type="species:ncbi:9606">Patients</span>
3.2. Concentrations of hsCRP in the Sera of Patients with IHD, MI, AP, and HT in Relation to MCP-1 -2851 (A/G) SNP Polymorphism and to Sex
###end title 27
###begin p 28
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 194 195 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 247 248 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 285 286 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 323 324 323 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">2 </xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">3</xref>
###xml 157 165 <span type="species:ncbi:9606">patients</span>
###xml 189 192 <span type="species:ncbi:9606">men</span>
###xml 207 212 <span type="species:ncbi:9606">women</span>
###xml 242 245 <span type="species:ncbi:9606">men</span>
###xml 260 265 <span type="species:ncbi:9606">women</span>
###xml 298 301 <span type="species:ncbi:9606">men</span>
###xml 316 321 <span type="species:ncbi:9606">women</span>
The tested SNP of MCP-1 gene, concretely the presence of the mutant G allele, statistically significantly correlated with the higher serum level of hsCRP in patients with IHD (P = .016; in men: P = .060; in women: P = .197), AP (P = .004; in men: P = .019; in women: P = .091) and HT (P = .013; in men: P = .047; in women: P = .122, Tables 2  and 3).
###end p 28
###begin p 29
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
The association between the serum level of hsCRP with the tested MCP-1 -2518 (A/G) SNP was not statistically significant either in patients with MI (P = .494) or in healthy control subjects (P = .787).
###end p 29
###begin p 30
###xml 0 136 0 136 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="31">Bonferroni's Post hoc Test (Correlations between Individual Genotypes with the Level of hsCRP in Serum of Patients and Healthy Subjects)</title>
###xml 345 346 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 388 389 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 454 455 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 136 474 136 474 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="32">This test showed differences in the serum levels of hsCRP comparing subjects with typical genotypes&#8212;AA : AG, AG : GG, and AA : GG. We found statistically significant differences in patients with IHD (AG : GG; <italic>P</italic> = .022, AA : GG; <italic>P</italic> = .018), AP (AG : GG; <italic>P</italic> = .003, AA : GG; <italic>P</italic> = .012), and HT (AG : GG; <italic>P</italic> = .016, AA : GG; <italic>P</italic> = .016) (<xref ref-type="table" rid="tab2">Table 2</xref>).</p>
###xml 0 474 0 474 <statement xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="head2"><title textid="31">Bonferroni's Post hoc Test (Correlations between Individual Genotypes with the Level of hsCRP in Serum of Patients and Healthy Subjects)</title><p textid="32">This test showed differences in the serum levels of hsCRP comparing subjects with typical genotypes&#8212;AA : AG, AG : GG, and AA : GG. We found statistically significant differences in patients with IHD (AG : GG; <italic>P</italic> = .022, AA : GG; <italic>P</italic> = .018), AP (AG : GG; <italic>P</italic> = .003, AA : GG; <italic>P</italic> = .012), and HT (AG : GG; <italic>P</italic> = .016, AA : GG; <italic>P</italic> = .016) (<xref ref-type="table" rid="tab2">Table 2</xref>).</p></statement>
###xml 106 114 <span type="species:ncbi:9606">Patients</span>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
Bonferroni's Post hoc Test (Correlations between Individual Genotypes with the Level of hsCRP in Serum of Patients and Healthy Subjects)This test showed differences in the serum levels of hsCRP comparing subjects with typical genotypes-AA : AG, AG : GG, and AA : GG. We found statistically significant differences in patients with IHD (AG : GG; P = .022, AA : GG; P = .018), AP (AG : GG; P = .003, AA : GG; P = .012), and HT (AG : GG; P = .016, AA : GG; P = .016) (Table 2).
###end p 30
###begin title 31
###xml 106 114 <span type="species:ncbi:9606">Patients</span>
Bonferroni's Post hoc Test (Correlations between Individual Genotypes with the Level of hsCRP in Serum of Patients and Healthy Subjects)
###end title 31
###begin p 32
###xml 209 210 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 252 253 252 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 318 319 318 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 329 336 329 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
This test showed differences in the serum levels of hsCRP comparing subjects with typical genotypes-AA : AG, AG : GG, and AA : GG. We found statistically significant differences in patients with IHD (AG : GG; P = .022, AA : GG; P = .018), AP (AG : GG; P = .003, AA : GG; P = .012), and HT (AG : GG; P = .016, AA : GG; P = .016) (Table 2).
###end p 32
###begin p 33
###xml 0 153 0 153 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="34">Bonferroni's Post hoc Test (Correlations between Individual Genotypes with the Level of hsCRP in Serum of Patients and Healthy Subjects According to Sex)</title>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 239 240 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 153 298 153 298 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="35">We revealed high significant correlations in men with AP (AG : GG; <italic>P</italic> = .037, AA : GG; <italic>P</italic> = .026) and in men with HT (AA : GG; <italic>P</italic> = .044) (<xref ref-type="table" rid="tab3">Table 3</xref>).</p>
###xml 0 298 0 298 <statement xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="head3"><title textid="34">Bonferroni's Post hoc Test (Correlations between Individual Genotypes with the Level of hsCRP in Serum of Patients and Healthy Subjects According to Sex)</title><p textid="35">We revealed high significant correlations in men with AP (AG : GG; <italic>P</italic> = .037, AA : GG; <italic>P</italic> = .026) and in men with HT (AA : GG; <italic>P</italic> = .044) (<xref ref-type="table" rid="tab3">Table 3</xref>).</p></statement>
###xml 106 114 <span type="species:ncbi:9606">Patients</span>
###xml 198 201 <span type="species:ncbi:9606">men</span>
###xml 256 259 <span type="species:ncbi:9606">men</span>
Bonferroni's Post hoc Test (Correlations between Individual Genotypes with the Level of hsCRP in Serum of Patients and Healthy Subjects According to Sex)We revealed high significant correlations in men with AP (AG : GG; P = .037, AA : GG; P = .026) and in men with HT (AA : GG; P = .044) (Table 3).
###end p 33
###begin title 34
###xml 106 114 <span type="species:ncbi:9606">Patients</span>
Bonferroni's Post hoc Test (Correlations between Individual Genotypes with the Level of hsCRP in Serum of Patients and Healthy Subjects According to Sex)
###end title 34
###begin p 35
###xml 67 68 67 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 136 143 136 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 45 48 <span type="species:ncbi:9606">men</span>
###xml 103 106 <span type="species:ncbi:9606">men</span>
We revealed high significant correlations in men with AP (AG : GG; P = .037, AA : GG; P = .026) and in men with HT (AA : GG; P = .044) (Table 3).
###end p 35
###begin title 36
4. Discussion
###end title 36
###begin p 37
###xml 688 690 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 973 975 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
###xml 727 735 <span type="species:ncbi:9606">patients</span>
Understanding the factors that directly or indirectly regulate the CRP release at baseline and during inflammation is very important in context of coronary risk prediction. More scientific groups studied CRP gene polymorphisms and found that basal levels of CRP both in patients and healthy controls are genetically determined and under repeated examination in healthy subjects relatively stable. Thus understanding the genetic background of CRP that regulates basal but also by infection or any type of inflammation-induced concentration of CRP might contribute to stratification of healthy subjects to different groups with higher or lower degree of cardiovascular disease development [21-24]. D'Aiuto et al. [25] found that patients with homozygous +1444TT allele of CRP gene had significantly higher serum level of CRP induced by inflammatory stimulus. The production of CRP is, except of CRP gene, regulated also by other genes coding for IL-6, IL-1 beta, and IL-1Ra [26, 27].
###end p 37
###begin p 38
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human CRP gene lies on chromosome 1, within a conserved region that encodes for proteins critical to the immune system and to intercellular communication [6, 28]. Dupuis et al. [29] found that multiple genes on chromosome 1 may influence inflammatory biomarker levels and may have a potential role in development of cardiovascular disease. They hypothesized that production of biomarkers of vascular inflammation is modulated genetically and by environmental factors.
###end p 38
###begin p 39
###xml 259 260 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 353 360 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
In the first part of our study we compared the serum levels of hsCRP in patients with IHD, AP, MI, and HT with the level in control subjects and found that serum levels of hsCRP in patients with AP were higher than those in control group of healthy subjects (P = .043). These levels were higher also in comparison to IHD patients without AP (P = .026) (Table 1).
###end p 39
###begin p 40
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 281 288 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 545 552 545 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 161 169 <span type="species:ncbi:9606">patients</span>
###xml 276 279 <span type="species:ncbi:9606">men</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
###xml 673 676 <span type="species:ncbi:9606">men</span>
The tested MCP-1 -2518 (A/G) SNP, concretely the presence of the mutant G allele, statistically significantly correlated with the higher serum level of hsCRP in patients with IHD (P = .016), AP (P = .004), and HT (P = .013), and in all cases higher correlations were found in men (Table 3). Comparing subjects with typical genotypes (AA, AG, GG), Bonferroni's post hoc test showed differences in the serum levels of hsCRP in patients with IHD, AP, and HT. The highest levels of hsCRP were associated with the presence of homozygous GG genotype (Table 2). The test also revealed high significant correlations of the presence of G allele with the elevated levels of hsCRP in men with AP and HT.
###end p 40
###begin title 41
5. Conclusion
###end title 41
###begin p 42
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Our results suggest that MCP-1 -2518 (A/G) SNP is associated with the level of hsCRP in patients with ischemic heart disease, angina pectoris, and hypertension in the Slovak population. The highest levels of hsCRP were found in subjects with homozygous GG genotype.
###end p 42
###begin title 43
Acknowledgments
###end title 43
###begin p 44
This work was supported by the Grant VEGA 1/0528/03 and in part by Czech and Slovak Ministries of Schools and Education, projects Kontakt 1/SK-CZ-02806, MSM6198959205, and ME-856.
###end p 44
###begin article-title 45
Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease
###end article-title 45
###begin article-title 46
Coronary spasm is associated with chronic low-grade inflammation
###end article-title 46
###begin article-title 47
Inflammation: an important mechanism for different clinical entities of coronary artery diseases
###end article-title 47
###begin article-title 48
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
###end article-title 48
###begin article-title 49
###xml 63 66 <span type="species:ncbi:9606">men</span>
###xml 71 76 <span type="species:ncbi:9606">women</span>
Inflammatory markers and the risk of coronary heart disease in men and women
###end article-title 49
###begin article-title 50
Relation of polymorphism within the C-reactive protein gene and plasma CRP levels
###end article-title 50
###begin article-title 51
###xml 69 72 <span type="species:ncbi:9606">men</span>
Inflammatory markers and long-term risk of ischemic heart disease in men: a 13-year follow-up of the Quebec Cardiovascular Study
###end article-title 51
###begin article-title 52
C-reactive protein: a critical update
###end article-title 52
###begin article-title 53
C-reactive protein, cytokines and inflammation in cardiovascular diseases
###end article-title 53
###begin article-title 54
Association of chronic stable angina pectoris with MCP-1-2518 A/G single nucleotide polymorphism in the Slovak population
###end article-title 54
###begin article-title 55
Monocyte chemoattractant protein-1 (MCP-1): an overview
###end article-title 55
###begin article-title 56
Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death
###end article-title 56
###begin article-title 57
CCL2/Monocyte chemoatractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts
###end article-title 57
###begin article-title 58
###xml 57 65 <span type="species:ncbi:9606">patients</span>
MCP-1 -2518 A/G single nucleotide polymorphism in Slovak patients with systemic sclerosis
###end article-title 58
###begin article-title 59
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Computer-assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease
###end article-title 59
###begin article-title 60
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 60
###begin article-title 61
Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
###end article-title 61
###begin article-title 62
The MCP-1 -2518 (A to G) single nucleotide polymorphism is not associated with myocardial infarction in the Czech population
###end article-title 62
###begin article-title 63
Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis
###end article-title 63
###begin article-title 64
Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene
###end article-title 64
###begin article-title 65
Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey
###end article-title 65
###begin article-title 66
Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level
###end article-title 66
###begin article-title 67
Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level
###end article-title 67
###begin article-title 68
C-reactive protein (+1444 C > T) polymorphism influences CRP response following a moderate inflammatory stimulus
###end article-title 68
###begin article-title 69
###xml 111 119 <span type="species:ncbi:9606">patients</span>
C-reactive protein levels and common polymorphisms of the interleukin-1 gene cluster and interleukin-6 gene in patients with coronary heart disease
###end article-title 69
###begin article-title 70
Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein
###end article-title 70
###begin article-title 71
A C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in Pima Indians
###end article-title 71
###begin article-title 72
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q
###end article-title 72
###begin p 73
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Serum levels of hsCRP in patients with IHD, MI, AP, and hypertension and in control group of healthy subjects. Legend: IHD: ischemic heart disease; MI: myocardial infarction; AP: angina pectoris; HT: hypertension.
###end p 73
###begin p 74
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Serum levels of hsCRP in patients with IHD, MI, AP, and HT in relation to the tested MCP-1 -2851 (A/G) SNP. Legend: IHD: ischemic heart disease; MI: myocardial infarction; AP: angina pectoris; HT: hypertension; Sg.: significance; SD: standard deviation.
###end p 74
###begin p 75
###xml 25 33 <span type="species:ncbi:9606">patients</span>
Serum levels of hsCRP in patients with IHD, MI, AP, and HT in relation to the tested MCP-1 -2851 (A/G) SNP and to sex. Legend: IHD: ischemic heart disease; MI: myocardial infarction; AP: angina pectoris; HT: hypertension; Sg.: significance; SD: standard deviation.
###end p 75

